Your session is about to expire
← Back to Search
Sirolimus 2Mg Tab for Cancer
Study Summary
This trial will test the effectiveness of sirolimus in treating metastatic dMMR solid cancer.
- Metastatic dMMR Solid Cancer
- Solid Tumors
- Cancer
- Metastatic Tumor
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What indications is Sirolimus 2Mg Tab most often prescribed for?
"Sirolimus 2Mg Tab is a medication that can help patients who have received a liver transplant and are struggling with rejection. Additionally, this drug has potential to improve kidney disease and renal angiomyolipomas."
How many patients are being enrolled in this trial?
"That is correct. The listing on clinicaltrials.gov suggests that the study team is still recruiting patients for this trial. This particular research project was first posted on June 3rd, 2020 and has been edited as recently as June 3rd, 2022. They are looking for a total of 16 individuals who meet the eligibility criteria across 1 site."
Are people still being signed up to participate in this drug trial?
"The information on clinicaltrials.gov does show that this study is looking for 16 participants at 1 location and it was originally posted on 6/3/2020 with the most recent edit being on 6/3/2022."
If I meet the requirements, can I sign up for this clinical trial?
"The 16 patients that will be allowed to participate in this clinical trial must have a malignant tumor and fall in the age range of 18 to 65 years old."
Are there any other examples in the medical literature of Sirolimus 2Mg Tab being used?
"Currently, there are 130 clinical trials involving Sirolimus 2Mg Tab underway. Of these studies, 13 are in Phase 3. The locations of these trials span 1084 different sites with several being based in Cincinnati, Ohio."
Does this research require that participants be over 30 years of age?
"In order to be eligible for this specific study, patients must fall within the age range of 18-65. There are 447 trials that test subjects under 18 and 2960 research projects for individuals over 65 years old."
Are there any negative health effects associated with Sirolimus 2Mg Tab?
"Sirolimus 2Mg Tab received a safety score of 2 because there is some data supporting safety, but no clinical evidence yet demonstrating its efficacy."
Share this study with friends
Copy Link
Messenger